Levocarnitine
Pricing Report NDC 50383-172-90

Latest NADAC: $0.84324 per EA · Effective Feb 22, 2023 · Est. package price $75.89 (90 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Levocarnitine (NDC 50383-172-90) is $0.84324 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 22, 2023.

As a provided by Akorn, this medication is distributed in a 9 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.84324
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Feb 22, 2023
Billable Units
90 EA
Estimated Package Price
$75.89
Data Status
As of Jun 28, 2023
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
50383-172-90
Description
9 BLISTER PACK in 1 CARTON / 10 TABLET in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.49829 to $0.86762 per EA. Over this 9 years and 3 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.4983 - $0.8676
Market Volatility
74.12% Variance
Latest Trend
No Change

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Feb 22, 2023 $0.84324 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 22, 2023 $0.84324 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Feb 15, 2023 $0.84324 EAC/I - Chain or Independent PharmacyCode 3, 6G - Generic
Jan 18, 2023 $0.60882 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 21, 2022 $0.81682 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 23, 2022 $0.86762 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 22, 2022 $0.84710 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 22, 2022 $0.84710 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
May 25, 2022 $0.70749 EAC/I - Chain or Independent PharmacyCode 3, 6G - Generic
May 18, 2022 $0.62793 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 20, 2022 $0.69594 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 19, 2018 $0.70128 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026